-
Subject Areas on Research
-
A histopathologic study of retinal arterial aneurysms.
-
A reappraisal of the concept of an abnormality of glutamine metabolism in primary gout.
-
Acute gout presenting in the manubriosternal joint.
-
Agency and structure in the sociology of sickness.
-
An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome.
-
Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG Trial.
-
Antioxidant properties of citric acid interfere with the uricase-based measurement of circulating uric acid.
-
Aspiration of the asymptomatic metatarsophalangeal joint in gout patients and hyperuricemic controls.
-
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER.
-
Association of Gout With Long-Term Cardiovascular Outcomes Among Patients With Obstructive Coronary Artery Disease.
-
Biochemical profile of stone-forming patients with diabetes mellitus.
-
Circulating galectin-3 in infections and non-infectious inflammatory diseases.
-
Clinical Images: a not-so crystal-clear ankle mass.
-
Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.
-
Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation.
-
Colchicine--Update on mechanisms of action and therapeutic uses.
-
Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout.
-
Computed Tomography: State-of-the-Art Advancements in Musculoskeletal Imaging.
-
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
-
Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore.
-
Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.
-
Editorial Commentary: Prevention and treatment of atrial fibrillation: Is hyperuricemia the next target?
-
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study.
-
Ethnic background has minimal impact on the etiology of nephrolithiasis.
-
Familial hyperuricemia and renal insufficiency.
-
Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study.
-
Fine-needle aspiration cytology of articular and periarticular lesions.
-
Gout and the regulation of purine biosynthesis.
-
Gout as a source of sesamoid pain.
-
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.
-
Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
-
Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
-
Gout, tophi and the wonders of NETs.
-
Gout: no longer the disease of kings.
-
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients.
-
Long-term colchicine administration leading to colchicine toxicity and death.
-
Medical management of acute gout.
-
Migration and gout: the Tokelau Island migrant study.
-
Molecular abnormalities of human plasminogen isolated from synovial fluid of rheumatoid arthritis patients.
-
Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis?
-
Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
-
Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
-
Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart.
-
Reassessing serum urate targets in the management of refractory gout: can you go too low?
-
Renal calculi: pathogenesis, diagnosis, and medical therapy.
-
Rheumatologic manifestations of cancer.
-
The current state of care in gout: Addressing the need for better understanding of an ancient disease.
-
The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.
-
The kinetics of intramolecular distribution of 15N in uric acid following administration of 15N-glycine: preferential labeling of N-(3+9) of uric acid in primary gout and a reappraisal of the "glutamine hypothesis".
-
Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.
-
Uricase and other novel agents for the management of patients with treatment-failure gout.
-
What Can We Learn From Studies Linking Gout With Dementia?
-
Keywords of People
-
Allen, Nancy Bates,
Professor Emeritus of Medicine,
Medicine, Rheumatology and Immunology
-
Ostbye, Truls,
Professor of Family Medicine and Community Health,
Family Medicine and Community Health
-
Preminger, Glenn Michael,
James F. Glenn, M.D. Distinguished Professor of Urology,
Surgery, Urology